Stock listing
BOATS:BJDX Bluejay Diagnostics, Inc. Stock
US listing (BOATS) of Bluejay Diagnostics, Inc. · home listing NASDAQ:BJDX
Follow Bluejay Diagnostics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:BJDX
$1.70 USD -0.13 (-7.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:BJDX
- Day range
- $1.62 – $1.80 USDNov 20, 2026
- Volume
- 22,320 sharesNov 20, 2026
- Market cap
- $1.90M USDAt the close on Nov 20, 2026 · price × 1.12M shares outstanding
- 52-week range
- $0.52 – $7.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $334,277 USDMedian day 35,850 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BJDX · Home | $1.70 USD | -0.13 (-7.1%) | 22,320 | $1.73 | $1.80 | $1.62 | $1.83 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BJDX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.70 | -0.13 | -7.1% | $1.73 | $1.80 | $1.62 | 22,320 | |
| $1.83 | -0.325 | -15.1% | $2.29 | $2.29 | $1.79 | 126,459 | |
| $2.155 | -0.135 | -5.9% | $2.29 | $2.30 | $2.12 | 17,425 | |
| $2.29 | -0.32 | -12.3% | $2.68 | $2.68 | $2.26 | 6,871 | |
| $2.61 | +0.005 | +0.2% | $2.444 | $3.043 | $2.444 | 37,029 | |
| $2.605 | -0.195 | -7.0% | $2.65 | $2.80 | $2.50 | 17,708 | |
| $2.80 | -0.01 | -0.4% | $2.77 | $2.80 | $2.65 | 16,474 | |
| $2.81 | +0.32 | +12.9% | $2.52 | $2.90 | $2.43 | 45,670 | |
| $2.49 | +0.14 | +6.0% | $2.30 | $2.60 | $2.30 | 32,660 | |
| $2.35 | +0.16 | +7.3% | $2.22 | $2.41 | $2.22 | 16,900 | |
| $2.19 | -0.10 | -4.4% | $2.25 | $2.33 | $2.10 | 44,900 | |
| $2.29 | +0.08 | +3.6% | $2.15 | $2.62 | $2.15 | 173,000 | |
| $2.21 | +0.09 | +4.2% | $2.14 | $2.84 | $2.021 | 445,400 | |
| $2.12 | -0.104 | -4.7% | $2.10 | $2.324 | $2.00 | 49,425 | |
| $2.224 | +1.684 | +311.9% | $2.12 | $2.40 | $1.84 | 70,225 | |
| $0.54 | -0.029 | -5.1% | $0.58 | $0.58 | $0.52 | 24,525 | |
| $0.569 | -0.008 | -1.4% | $0.577 | $0.60 | $0.562 | 9,875 | |
| $0.577 | +0.017 | +3.0% | $0.57 | $0.616 | $0.57 | 8,750 | |
| $0.56 | -0.025 | -4.3% | $0.591 | $0.60 | $0.56 | 24,625 | |
| $0.585 | -0.044 | -7.0% | $0.632 | $0.65 | $0.585 | 10,950 | |
| $0.629 | -0.047 | -7.0% | $0.692 | $0.70 | $0.623 | 9,075 | |
| $0.676 | +0.005 | +0.7% | $0.67 | $0.709 | $0.67 | 7,900 | |
| $0.671 | -0.025 | -3.6% | $0.681 | $0.695 | $0.665 | 12,075 | |
| $0.696 | -0.049 | -6.6% | $0.74 | $0.744 | $0.695 | 17,675 | |
| $0.745 | -0.034 | -4.4% | $0.77 | $0.77 | $0.73 | 18,725 | |
| $0.779 | -0.008 | -1.0% | $0.77 | $0.78 | $0.757 | 22,000 | |
| $0.787 | -0.045 | -5.4% | $0.818 | $0.821 | $0.77 | 18,775 | |
| $0.832 | +0.04 | +5.1% | $0.806 | $0.832 | $0.783 | 83,750 | |
| $0.792 | -0.032 | -3.9% | $0.801 | $0.805 | $0.762 | 34,825 | |
| $0.824 | +0.008 | +1.0% | $0.815 | $0.83 | $0.794 | 23,500 | |
| $0.816 | +0.006 | +0.7% | $0.799 | $0.834 | $0.786 | 23,375 | |
| $0.81 | -0.001 | -0.1% | $0.786 | $0.84 | $0.775 | 63,700 | |
| $0.811 | +0.05 | +6.6% | $0.78 | $0.84 | $0.763 | 1,733,500 | |
| $0.761 | -0.076 | -9.1% | $0.841 | $0.849 | $0.755 | 98,475 | |
| $0.837 | -0.009 | -1.1% | $0.847 | $0.85 | $0.83 | 28,650 | |
| $0.846 | -0.009 | -1.1% | $0.86 | $0.866 | $0.835 | 14,875 | |
| $0.855 | -0.084 | -8.9% | $0.937 | $0.938 | $0.83 | 98,850 | |
| $0.939 | -0.021 | -2.2% | $0.96 | $0.97 | $0.926 | 66,200 | |
| $0.96 | +0.039 | +4.2% | $0.935 | $0.96 | $0.925 | 62,300 | |
| $0.921 | -0.029 | -3.1% | $0.951 | $0.96 | $0.91 | 71,575 | |
| $0.95 | -0.019 | -2.0% | $0.931 | $0.989 | $0.93 | 49,550 | |
| $0.969 | -0.031 | -3.1% | $0.94 | $0.971 | $0.90 | 184,150 | |
| $1.00 | +0.088 | +9.6% | $0.91 | $1.03 | $0.90 | 1,130,300 | |
| $0.912 | -0.008 | -0.9% | $0.931 | $0.94 | $0.90 | 53,600 | |
| $0.92 | +0.075 | +8.9% | $0.848 | $0.96 | $0.848 | 224,175 | |
| $0.845 | +0.032 | +3.9% | $0.81 | $0.875 | $0.81 | 31,400 | |
| $0.813 | -0.035 | -4.1% | $0.849 | $0.88 | $0.80 | 35,275 | |
| $0.848 | -0.002 | -0.2% | $0.867 | $0.867 | $0.825 | 24,175 | |
| $0.85 | -0.047 | -5.2% | $0.864 | $0.88 | $0.85 | 46,075 | |
| $0.897 | -0.113 | -11.2% | $1.00 | $1.01 | $0.862 | 85,225 | |
| $1.01 | 0.00 | 0.0% | $0.97 | $1.019 | $0.962 | 76,425 | |
| $1.01 | -0.02 | -1.9% | $1.01 | $1.08 | $0.89 | 361,300 | |
| $1.03 | +0.198 | +23.8% | $1.025 | $1.09 | $0.912 | 11,556,650 | |
| $0.832 | -0.017 | -2.0% | $0.84 | $0.85 | $0.821 | 22,250 | |
| $0.849 | 0.00 | 0.0% | $0.84 | $0.86 | $0.82 | 35,850 | |
| $0.849 | +0.001 | +0.1% | $0.85 | $0.87 | $0.818 | 67,025 | |
| $0.848 | -0.022 | -2.5% | $0.834 | $0.86 | $0.823 | 43,700 | |
| $0.87 | -0.03 | -3.3% | $0.906 | $0.906 | $0.833 | 136,175 | |
| $0.90 | -0.01 | -1.1% | $0.92 | $1.239 | $0.884 | 2,843,200 | |
| $0.91 | +0.017 | +1.9% | $0.884 | $0.93 | $0.884 | 36,075 | |
| $0.893 | -0.023 | -2.5% | $0.922 | $0.946 | $0.89 | 19,525 | |
| $0.916 | +0.016 | +1.8% | $0.91 | $0.96 | $0.90 | 30,900 | |
| $0.90 | -0.011 | -1.2% | $0.93 | $0.93 | $0.892 | 20,775 | |
| $0.911 | -0.028 | -3.0% | $0.928 | $0.947 | $0.90 | 28,550 | |
| $0.939 | -0.021 | -2.2% | $0.946 | $0.96 | $0.916 | 39,975 |
Splits
4 splits since 2023 · NASDAQ:BJDX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-4 | Consolidation | |
| 1-for-50 | Consolidation | |
| 1-for-8 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- BOATS:BJDX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest news
Bluejay Diagnostics Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 12, 2026
Closed $2.61 (+0.2%) on Nov 13, 2026
Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Oct 30, 2026
Closed $2.22 (+311.9%) on Oct 30, 2026
Bluejay Achieves Toray Contractual Manufacturing Milestone, Advancing Supply-Chain Resilience and Commercialization Readiness
Oct 13, 2026
Closed $0.832 (+5.1%) on Oct 13, 2026
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Sep 8, 2026
Closed $1.03 (+23.8%) on Sep 8, 2026
Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ IL-6 Toward Regulatory Submission and Commercialization
Aug 13, 2026
Closed $1.06 (+1.0%) on Aug 13, 2026
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study
Jul 21, 2026
Closed $1.16 (-4.1%) on Jul 21, 2026
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Jun 5, 2026
Closed $5.23 (+9.0%) on Jun 8, 2026
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Jun 2, 2026
Closed $4.34 (+100.0%) on Jun 2, 2026
Bluejay Diagnostics and Argonaut Manufacturing Services Announce Strategic Partnership
Jun 2, 2026
Closed $4.34 (+100.0%) on Jun 2, 2026
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
May 7, 2026
Closed $1.72 (-5.5%) on May 8, 2026
Bluejay Diagnostics, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 17 in the last 12 months · 54 in all · newest Nov 12, 2026 · oldest 2021
Where Bluejay Diagnostics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BJDX · Home listing | NASDAQ | United States | USD |
| BOATS:BJDX · This page | BOATS | United States | USD |
Valuation
Price/book 0.3× against a median of 1.8×: 3rd lowest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$5.43M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.71
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. · NASDAQ:BJDX | US$1.90M | −US$5.43M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 1.71 |
| Telo Genomics Corp. · TSXV:TELO | US$2.80M | US$2.12M | n/a | n/a | n/a | n/a | n/a | n/a | 0.04 |
| Advanced Biomed Inc. · NASDAQ:ADVB | US$2.73M | US$3.12M | 0.5× | 12.2× | n/a | 0.2× | n/a | 0.1× | 0.35 |
| Innovotech Inc. · TSXV:IOT | US$2.66M | US$2.51M | n/a | 1.0× | n/a | 1.5× | −21.1% | 0.1× | 0.39 |
| Qlife Holding AB · OMXSTO:QLIFE | US$2.49M | US$2.88M | n/a | 34.1× | n/a | 9.6× | n/a | 3.1× | n/a |
| Physiomics PLC · LSE:PYC | US$2.46M | US$1.91M | n/a | 1.6× | n/a | 3.6× | −74.1% | 0.0× | n/a |
| 20/20 BioLabs, Inc. · NASDAQ:AIDX | US$2.10M | −US$1.01M | n/a | −0.5× | n/a | 3.4× | −317.8% | 0.9× | 1.41 |
| Accustem Sciences Inc · OTC:ACUT | US$1.90M | US$1.88M | n/a | n/a | n/a | n/a | n/a | n/a | 0.19 |
| InVitro International · OTC:IVRO | US$1.87M | US$644,260 | 29.6× | 0.8× | 14.0× | 1.1× | 8.2% | 0.0× | 0.17 |
| Co-Diagnostics, Inc. · NASDAQ:CODX | US$1.36M | US$2.21M | n/a | 2.6× | n/a | 0.1× | n/a | 0.2× | 2.16 |
| Prostatype Genomics AB · OMXSTO:PROGEN | US$1.36M | US$1.32M | n/a | 13.3× | n/a | 2.1× | n/a | 0.0× | n/a |
| Median of the others | US$2.28M | US$2.02M | 15.1× | 2.1× | 14.0× | 1.8× | −47.6% | 0.1× | 0.35 |
Team and board
Officers
| Officer | Role |
|---|---|
| Indranil Dey | President, Chief Executive Officer and Director |
| Gordon Kinder | Chief Financial Officer |
| Jason Cook | Chief Technology Officer |
Board
| Director | Role |
|---|---|
| Douglas C. Wurth | Director and Chairman of the Board |
| Donald R. Chase | Director |
| Fred S. Zeidman | Director |
| Gary Gemignani | Director |
| Indranil Dey | President, Chief Executive Officer and Director |
| Svetlana Dey | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 12, 2026 | −6.8% |
| Q2 2026 | Aug 12, 2026 | −0.9% |
| Q1 2026 | May 29, 2026 | −0.5% |
| Q4 2025 | Mar 24, 2026 | −3.5% |
| Q3 2025 | Nov 7, 2025 | −1.3% |
| Q2 2025 | Aug 7, 2025 | −4.8% |
| Q1 2025 | May 13, 2025 | −3.9% |
| Q4 2024 | Mar 31, 2025 | −5.0% |
| Q3 2024 | Nov 29, 2024 | +1.4% |
| Q2 2024 | Aug 14, 2024 | −8.4% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 15, 2024 · After close | +9.5% |
| Q4 2023 | Mar 28, 2024 · After close | −4.0% |
| Q3 2023 | Nov 9, 2023 · After close | +5.7% |
| Q2 2023 | Aug 14, 2023 · After close | −2.2% |
| Q1 2023 | May 10, 2023 · Before open | +1.8% |
| Q4 2022 | Mar 20, 2023 · After close | −16.4% |
| Q3 2022 | Nov 8, 2022 · After close | −8.1% |
| Q2 2022 | Jul 26, 2022 · After close | −17.7% |
| Q1 2022 | Apr 20, 2022 · After close | +3.3% |
| Q4 2021 | Mar 10, 2022 · Before open | −6.5% |
Financings
| Raise | Date |
|---|---|
| Private placement of shares of common stock (or pre-funded warrants) and Series F warrants Closed: US$4.5M raised · US$2 a share · ½ warrant at US$1.75 for 66 months · Rodman and Renshaw LLC Dealers: Rodman and Renshaw LLC (lead) Use of proceeds: Matters related to obtaining FDA approval including clinical studies, other research and development, and general working capital | Oct 13, 2025 |
| Warrant exercise of shares of common stock on exercise of existing warrants Announced: about US$3.7M · US$3.42 a share · Warrants at US$3.42 for 60 months · Aegis Capital Corp. Dealers: Aegis Capital Corp. | Apr 7, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$10.00 a unit on Nov 9, 2021.
- Price
- US$10.00 a unit
- Units offered
- 2,160,000 units
- Offering size
- US$21.6 million
- Underwriters' option
- Up to 324,000 more units
- Listing
- BJDX on the Nasdaq Capital Market
- Underwriters
- Dawson James Securities, Inc., I-Bankers Direct, LLC · In the order on the cover
- Units delivered
- On or about Nov 15, 2021
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Jul 22, 2021 |
| Filed publicly | Oct 4, 2021 |
| Amended twice | Newest Nov 3, 2021 |
| Shares registered with an exchange | Nov 5, 2021 |
| Declared effective by the SEC | Nov 9, 2021 |
| Final prospectus, with the price | Nov 12, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Nov 12, 2021 |
| EFFECT · Notice that a registration is effective | Nov 9, 2021 |
| S-1MEF · Registration of more shares for the same offering | Nov 9, 2021 |
| CORRESP · Letter to the SEC | Nov 5, 2021 |
| CERT · Exchange's certificate of listing | Nov 5, 2021 |
| CORRESP · Letter to the SEC | Nov 5, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 5, 2021 |
| S-1/A · Registration statement, amended | Nov 3, 2021 |
| FWP · Free writing prospectus | Oct 27, 2021 |
| CORRESP · Letter to the SEC | Oct 25, 2021 |
All 19 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Oct 25, 2021 |
| UPLOAD · Letter from the SEC | Oct 15, 2021 |
| CORRESP · Letter to the SEC | Oct 4, 2021 |
| S-1 · Registration statement | Oct 4, 2021 |
| UPLOAD · Letter from the SEC | Sep 24, 2021 |
| DRSLTR · Letter to the SEC with a draft | Sep 8, 2021 |
| DRS/A · Draft registration statement, amended | Sep 8, 2021 |
| UPLOAD · Letter from the SEC | Aug 20, 2021 |
| DRS · Draft registration statement | Jul 22, 2021 |
Open IPO · From the cover of the final prospectus (424B4) filed Nov 12, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 249.0K | 75 | 0 | 0 |
| Cost of revenue | 170.7K | 199.1K | 781.0K | 200.1K | 145.7K | 157.0K | 143.0K |
| Gross profit | -170.7K | -199.1K | -781.0K | 48.9K | -145.7K | -157.0K | -143.0K |
| Research and development | 3.05M | 3.47M | 5.71M | 4.15M | 1.15M | 527.3K | 454.6K |
| Selling, general and administrative | 3.91M | 3.69M | 283.4K | 451.4K | 1.79M | 596.1K | 884.0K |
| Operating income | -6.95M | -7.17M | -10.3M | -9.32M | -3.23M | -1.20M | -1.63M |
| Depreciation and amortization | 74.2K | 75.6K | 648.7K | 156.6K | 145.7K | 157.0K | 143.0K |
| EBITDA | -6.88M | -7.09M | -9.66M | -9.16M | -3.08M | -1.04M | -1.49M |
| Interest expense | 839 | 823.0K | 0 | 20.8K | 6.36K | 59.3K | 0 |
| Income before tax | -6.85M | -7.72M | -9.95M | -9.30M | -3.49M | -1.16M | -819.8K |
| Income tax | 5 | -69.1K | 241.4K | -32.6K | -62.1K | ||
| Net income | -6.85M | -7.72M | -9.95M | -9.30M | -3.49M | -1.16M | -757.7K |
| Earnings per share, basic | -15.25 | -456.75 | -3,631.48 | -9.22 | -0.41 | -0.37 | -38.20 |
| Earnings per share, diluted | -15.25 | -456.75 | -3,631.48 | -9.22 | -0.41 | -0.37 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 5.16M | 4.30M | 2.21M | 10.1M | 19.0M | 912.4K | 96.0K |
| Receivables | 14.6K | 41.3K | 7.96K | 645 | |||
| Inventory | 0 | 84.8K | 123.5K | ||||
| Current assets | 5.46M | 4.90M | 3.22M | 11.8M | 20.7M | 1.06M | 300.3K |
| Property, plant and equipment | 1.53M | 1.51M | 1.29M | 1.23M | 337.4K | 459.1K | 616.2K |
| Total assets | 7.12M | 6.66M | 4.87M | 13.5M | 21.0M | 1.52M | 916.5K |
| Accounts payable | 214.3K | 145.1K | 491.5K | 635.8K | 295.8K | 374.9K | 29.1K |
| Current liabilities | 1.12M | 810.4K | 1.77M | 1.64M | 637.2K | 1.85M | 576.5K |
| Long-term debt | 804.3K | ||||||
| Total debt | 120.2K | 222.2K | 353.0K | 492.6K | 1.06M | 1.07M | |
| Total liabilities | 1.14M | 927.9K | 1.97M | 1.98M | 637.2K | 1.85M | 3.85M |
| Shareholders' equity | 5.98M | 5.73M | 2.89M | 11.5M | 20.4M | -4.21M | -2.93M |
| Shares outstanding | 151.1K | 138.5K | 3.10K | 1.01M | 20.1M | 3.15M | 19.8K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -6.05M | -7.82M | -8.31M | -7.74M | -4.37M | -508.7K | -1.69M |
| Capital spending | -173.7K | -306.8K | -704.2K | -1.20M | -23.9K | -23.9K | -6.02K |
| Free cash flow | -6.23M | -8.13M | -9.02M | -8.94M | -4.39M | -508.7K | -1.70M |
| Cash from investing | -173.7K | -306.8K | -704.2K | -1.20M | -23.9K | -23.9K | -6.02K |
| Cash from financing | 7.09M | 10.2M | 1.11M | 8.07K | 22.5M | 1.33M | 1.51M |
| Dividends paid | -17.7K | ||||||
| Share buybacks | -59.1K | 17.7K | |||||
| Change in cash | 862.9K | 2.09M | -7.91M | -8.93M | 18.1M | 816.4K | -184.3K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Nov 13, 2026 | Results | SEC |
| 10-Q · Quarterly report | Nov 12, 2026 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 10, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Nov 4, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Oct 13, 2026 | Current report | SEC |
| 8-K · Current report | Oct 6, 2026 | Current report | SEC |
| 8-K · Current report | Sep 8, 2026 | Material contract | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 13, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Aug 13, 2026 | Current report | SEC |
| S-8 · Registration statement for employee plans | Aug 12, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 12, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 22, 2026 | Current report | SEC |
| 4 · Change in ownership | Jul 22, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 22, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 10, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jul 10, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Jun 29, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Jun 26, 2026 | Offer document | SEC |
| S-3 · Registration statement | Jun 17, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 9, 2026 | Management or board change | SEC |
| 8-K · Current report | Jun 8, 2026 | Material contract | SEC |
| SCHEDULE 13G · Big-stake notice | Jun 5, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 2, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 2, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jun 2, 2026 | Material contract | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 7, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 7, 2026 | Results | SEC |
| DEF 14A · Proxy statement | Apr 30, 2026 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 20, 2026 | Meeting notice | SEC |
| 8-K · Current report | Apr 7, 2026 | Current report | SEC |
| 8-K · Current report | Mar 17, 2026 | Material contract | SEC |
| 8-K · Current report | Mar 16, 2026 | Current report | SEC |
| 8-K · Current report | Mar 12, 2026 | Current report | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 11, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 11, 2026 | Big-stake notice | SEC |
| SCHEDULE 13D · Big-stake notice | Mar 11, 2026 | Big-stake notice | SEC |
| 10-K · Annual report | Mar 6, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 6, 2026 | Results | SEC |
| 8-K · Current report | Feb 20, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 18, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 17, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 17, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 5, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 5, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 29, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Dec 30, 2025 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Nov 28, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Nov 26, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 25, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 10, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 7, 2025 | Quarterly report | SEC |
| S-3 · Registration statement | Oct 23, 2025 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 16, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 14, 2025 | Material contract | SEC |
| 8-K · Current report | Oct 9, 2025 | Material contract | SEC |
| 8-K · Current report | Aug 15, 2025 | Current report | SEC |
| 8-K · Current report | Aug 8, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 28, 2025 | Material contract | SEC |
| 8-K · Current report | Jun 18, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Jun 3, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jun 3, 2025 | Current report | SEC |
| 8-K · Current report | May 28, 2025 | Management or board change | SEC |
| DEF 14A · Proxy statement | May 16, 2025 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 13, 2025 | Quarterly report | SEC |
| 424B3 · Prospectus | May 8, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 8, 2025 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | May 5, 2025 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | May 5, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 2, 2025 | Other filings | SEC |
| S-3 · Registration statement | Apr 29, 2025 | Offer document | SEC |
| 10-K/A · Annual report, amended | Apr 29, 2025 | Annual report | SEC |
| 8-K · Current report | Apr 9, 2025 | Material contract | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 3, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Dec 4, 2024 | Current report | SEC |
| 8-K · Current report | Nov 18, 2024 | Meeting outcome | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 24, 2024 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Oct 16, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 16, 2024 | Current report | SEC |
| DEF 14A · Proxy statement | Sep 10, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Aug 30, 2024 | Meeting notice | SEC |
| 8-K · Current report | Aug 28, 2024 | Current report | SEC |
| 8-K · Current report | Aug 21, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Jul 16, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jul 5, 2024 | Meeting notice | SEC |
| SC 13G · Big-stake notice | Jul 3, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jun 28, 2024 | Material contract | SEC |
| 424B1 · Prospectus | Jun 27, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 27, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 25, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 25, 2024 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 24, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jun 24, 2024 | Other filings | SEC |
| 8-K · Current report | Jun 20, 2024 | Meeting outcome | SEC |
| S-1 · Registration statement | Jun 17, 2024 | Offer document | SEC |
| 8-K · Current report | May 31, 2024 | Material contract | SEC |
| 8-K · Current report | May 16, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| DEF 14A · Proxy statement | Apr 15, 2024 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Apr 5, 2024 | Meeting notice | SEC |
| 8-K · Current report | Apr 2, 2024 | Management or board change | SEC |
| 10-K · Annual report | Mar 28, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 1, 2024 | Current report | SEC |
| SC 13G · Big-stake notice | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 3, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 2, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Dec 29, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 28, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 27, 2023 | Offer document | SEC |
| 8-K · Current report | Dec 27, 2023 | Current report | SEC |
| CORRESP · Letter to the SEC | Dec 22, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 22, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 21, 2023 | Offer document | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 14, 2023 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Nov 30, 2023 | Other filings | SEC |
| S-1 · Registration statement | Nov 21, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 8-K · Current report | Oct 26, 2023 | Material contract | SEC |
| 8-K · Current report | Oct 16, 2023 | Management or board change | SEC |
| 3 · Initial statement of ownership | Oct 11, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 2, 2023 | Management or board change | SEC |
| 8-K · Current report | Aug 28, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Aug 28, 2023 | Offer document | SEC |
| 8-K · Current report | Aug 16, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 10, 2023 | Current report | SEC |
| 8-K · Current report | Jul 21, 2023 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | Jun 21, 2023 | Other filings | SEC |
| 8-K · Current report | Jun 20, 2023 | Meeting outcome | SEC |
| CORRESP · Letter to the SEC | Jun 15, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 15, 2023 | Other filings | SEC |
| S-3 · Registration statement | Jun 5, 2023 | Offer document | SEC |
| 8-K · Current report | May 19, 2023 | Current report | SEC |
| DEF 14A · Proxy statement | May 18, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 10, 2023 | Results | SEC |
| PRE 14A · Preliminary proxy statement | May 5, 2023 | Meeting notice | SEC |
| 10-K/A · Annual report, amended | May 1, 2023 | Annual report | SEC |
| 8-K · Current report | Apr 27, 2023 | Current report | SEC |
| 4/A · Change in ownership, amended | Mar 31, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Mar 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2023 | Insider trade | SEC |
| 10-K · Annual report | Mar 20, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 20, 2023 | Results | SEC |
| 3 · Initial statement of ownership | Mar 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 27, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 9, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 8, 2022 | Results | SEC |
| 8-K · Current report | Oct 28, 2022 | Current report | SEC |
| 4 · Change in ownership | Sep 7, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 10, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jul 26, 2022 | Results | SEC |
| 8-K · Current report | Jun 15, 2022 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | May 12, 2022 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 9, 2022 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 27, 2022 | Insider trade | SEC |
| 8-K · Current report | Apr 20, 2022 | Results | SEC |
| S-8 · Registration statement for employee plans | Apr 19, 2022 | Offer document | SEC |
| 8-K · Current report | Apr 1, 2022 | Management or board change | SEC |
| 8-K · Current report | Mar 28, 2022 | Management or board change | SEC |
| 4 · Change in ownership | Mar 28, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 28, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Mar 21, 2022 | Insider trade | SEC |
This page holds 200 of 252 filings. Open Filings
Cap table
Built by 6ix from Bluejay Diagnostics, Inc.’s releases · as of Nov 3, 2026
- Common shares
- 1,117,013
- Fully diluted
- 2,242,013
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 1,117,013 | Nov 3, 2026 |
| Warrants | 1,125,000 | Oct 10, 2025 |
Warrants and options
| Lot |
|---|
| Warrants · US$1.75 · expire about Apr 2031 |
Share count over time
| Count | Shares |
|---|---|
| Nov 3, 2026 | 1,117,013 |
| Nov 3, 2026 | |
| Oct 30, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Fred S. Zeidman Other companies: Graf Global Corp. (Director · Since at least Jun 25, 2024); Good Works II Acquisition Corp (Director · Jul 9, 2021 – Jul 8, 2022 · Past); Cipher Digital Inc. (CEO, Director · Oct 19, 2020 – Mar 10, 2021 · Past); Viking Global Technologies Inc (Director · Jan 11, 2018 – Jan 11, 2018 · Past); Straight Path Communications Inc (Director · Oct 13, 2017 – Feb 28, 2018 · Past) | Director · Since at least Nov 9, 2021 |
| Kenneth R Fisher Other companies: Provident Bancorp Inc (EVP and CFO · Since at least Mar 28, 2024); Meridian Bancorp Inc (EVP, Treasurer & CFO · Jun 1, 2020 – Nov 12, 2021 · Past) | Chief Financial Officer · Mar 23, 2022 – Feb 1, 2023 · Past |
| Donald R. Chase | Director · Since at least Mar 14, 2026 |
| Douglas C. Wurth | Director · Since at least Mar 14, 2026 |
| Gordon Kinder | Chief Financial Officer · Nov 9, 2021 – Mar 17, 2022 · Past |
| Indranil Dey | President and CEO, Director · Since at least Mar 14, 2026 |
| Svetlana Dey | Director · Since at least Nov 9, 2021 |
Log in to ask 6ix AI your own questions about Bluejay Diagnostics, Inc.